This impurity is primarily used as a reference standard in pharmaceutical analytical laboratories for the identification detection and quantification of nitrosamine impurities in valsartan active pharmaceutical ingredients (APIs) and finished dosage forms.

The purpose of monitoring this impurity is to ensure the quality safety and regulatory compliance of valsartan products by confirming that nitrosamine impurity levels remain below acceptable limits established by health authorities.

N-nitroso-valsartan Cyano-desvalerylmethylester Impurity is a structurally modified nitrosated derivative related to valsartan. It contains a nitroso functional group and is considered a process- or degradation-related impurity that may arise under certain manufacturing conditions involving nitrosating agents and amine-containing intermediates.